Acne Treatment Market - Forecasts from 2023 to 2028

The acne treatment market is expected to grow at a CAGR of 3.84% from US$188.107 million in 2021 to US$244.81 million in 2028.

When hair follicles become clogged with oil and dead skin cells, acne is a skin disorder that develops. It results in pimples, blackheads, or whiteheads. Although it can afflict anyone at any age, acne is most prevalent in teenagers. The growing prevalence of acne along with the rising adolescent population are the primary growth drivers of the acne treatment market.

Growing Prevalence of Acne Globally

The growing prevalence of acne due to factors such as changing lifestyles, genetics, and untimely routine is a major growth factor in the acne treatment market. According to the IHME, around 4.96 million people had acne vulgaris causing Disability-adjusted life year (DALY) in 2019 out of which, 3.52 million occurred in people aged between 15-49 years old. Moreover, acne in adults is increasing indicating the need for treatment thereby propelling the acne treatment market. According to the American Academy of Dermatology Association (AADA), around 15% of women are affected with acne annually which further widens the acne treatment market size as women are expected to be more image-conscious.

Rising Adolescent Population

The major cause of clogging and acne development is age as teenagers and younger adults are more affected by the acne. The rising global adolescent population causing more acne is indicating the acne treatment market expansion in the coming years. According to UNICEF, there were 1.3 billion adolescents worldwide in April 2022 making up almost 16% of the total world population. According to Jon Hopkins, Girls are typically affected earlier than boys, and it usually starts around the beginning of puberty. In most cases, acne is outgrown, although about 12% of women and 3% of men may still have acne in their 40s. Moreover, acne may cause emotional and psychological problems in a person. The growing teenage population along with the severe emotional impact of acne is contemplated to bolster the acne treatment market size.

Technological Advancements and Related Programs

The advances in technology are helping in the development of enhanced acne treatments which is propelling the acne treatment market. According to Cosmetic Surgery Forum Faculty members, Energy-based devices nearly always expedite the healing process, which is crucial for acne sufferers who don't want to wait the standard eight to 12 weeks for results. Additionally, other related efforts are further boosting the acne treatment market. For instance, the British Columbia Health Care system launched a website in June 2023 to book appointments with pharmacists for the treatment of minor ailments including acne.

Opportunities in the Market

The growing prevalence of acne problems along with the rising adolescent population is rapidly aiding the acne treatment market growth thereby providing an opportunity for market players to enhance the customer experience. Moreover, the problem of acne also happens from bad diet, poor hygiene, and sanitation which are also prevailing in adults. For instance, 5 out of 10 adults and 6 out of 10 children between the ages of 2 and 19 regularly consume one or more sugary beverages as per the CDC estimates. These factors causing the higher prevalence of acne further provide a phenomenal opportunity to enter the acne treatment market.

Restraints in the Market

Apart from all the growth factors, a few side effects of acne treatments are expected to limit the acne treatment market growth. The common side effects of topical acne drugs are dryness and irritation which are temporary. The more serious side effects can occur in the case of oral medications such as indigestion, or dizziness caused by antibiotics. Moreover, acne treatment medications can increase the risk of blood clots and high blood pressure in women taking birth control pills. Serious side effects from oral isotretinoin (a drug for severe acne) are possible, particularly if you become pregnant while taking it. According to reports, babies born to mothers who used isotretinoin during pregnancy had serious birth defects.

North America is Expected To Grow at a High Rate During The Forecast Period

North America is expected to hold a significant share of the acne treatment market during the forecast period. The factors attributed to such a share are a huge number of acne-affected people along with higher adoption of acne treatments. For instance, nearly 50 million Americans are affected with acne annually and it is the most common prevailing skin condition in the US as per the AADA. The estimates of the AADA suggest that around 85% of people get affected with at least minor acne and are aged between 12-24 years. Moreover, the presence of major market players such as Obagi, Skinmedica, and Colorescience further contributes significantly to the acne treatment market growth through product launches and easy accessibility.

Acne Treatment Market Players

• Sente, founded in 2007 is helping physicians to address uneven skin concerns through several clinical tests. Medical experts have long employed therapeutically developed heparan sulfate analog (HSA) by the company to support the body's inflammatory healing process.
• Obagi, a US-based transformative skincare company is serving the population for the last 35 years providing solutions for all skin types and tones. The company provides acne solutions through its Clenziderm Therapeutic lotion, Obagi 360 Retinol 1.0, Obagi Clinical Retinol 0.5 Retexturizing Cream, and Obagi 360 Retinol 0.5.
• Revision Skincare offers disruptive skincare innovation with a mission to deliver benefits through products that patients can see. The company provides solutions to numerous skin concerns including loss of firmness, aging eyes, wrinkles, hyperpigmentation, fatigued skin, and acne.

Key Market Developments

• In September 2022, a new Effaclar Salicyclic Acid Acne Treatment Serum was launched by La Roche Posay to specifically target adult acne. Effaclar Serum's Triple Acid Complex formula, which combines glycolic acid, lipo-hydroxy acid, and 1.5% salicylic acid, clears acne scars while assisting in the prevention of future outbreaks.
• In July 2022, the first topical Minocycline 4% gel for the treatment of moderate to severe acne was introduced by Glenmark in India. This gel is suitable for people aged 9 years or above and compared to other topical antibacterial formulations available, it offers the lowest MIC90.
• In November 2021, a new acne treatment cream Winlevi developed by Sun Pharma was launched in the US market. The Winlevi cream is suitable for people aged 12 years and above and it was also the first FDA-approved acne drug with a first-in-class mechanism in the last 40 years.

Segmentation:

By Product

• Retinoids
• Antibiotics
• Isotretinoin
• Others

By Route of Administration

• Oral
• Tropical

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others